Related StoriesNew vaccine candidate shows great promise at fighting respiratory syncytial virusHIV, Ebola look like of pet originStudy provides novel insight into the evolution of hepatitis A virus and how it spreads to human beings The first weak spot was identified at transmitting, when the virus has to survive the transfer from one individual to another, Dr Bull said. The second weakness, and surprise obtaining, was the significant drop in the diversity of the viral variants in each individual studied, occurring around three months after transmission, around the proper time where the immune system is starting to fight the virus.Medicare's impact on quality senior health care along with equitable service provider reimbursement are significant issues-and will become more so while the baby boomer generation continues to age group and enter Medicare's ranks, noted Dr. Hamm.
AZD3965 drug inhibits development of tumours in the lab Manchester scientists have shown that a new drug inhibits the development of tumours in the laboratory and that its effectiveness is improved by combining it with radiotherapy – suggesting a fresh approach that may be used in the clinic. Many tumours have got regions of hypoxia, where there’s a shortage of oxygen. These tumours show a switch in energy production – they switch to using glycolysis, which creates lactate as a by-product.